NO20005004L - Azabicykiske 5HT 1 reseptorligander - Google Patents

Azabicykiske 5HT 1 reseptorligander

Info

Publication number: NO20005004L
Authority: NO; Norway
Prior art keywords: azabicyclic; receptor ligands; ligands; receptor
Prior art date: 1998-04-09

Application number

NO20005004A

Other languages

English (en)

Other versions

NO20005004D0 (no

Inventor

Gene Michael Bright

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-09

Filing date

2000-10-04

Publication date

2000-11-27

2000-10-04 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-10-04 Publication of NO20005004D0 publication Critical patent/NO20005004D0/no

2000-11-27 Publication of NO20005004L publication Critical patent/NO20005004L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Psychology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Luminescent Compositions (AREA)

NO20005004A 1998-04-09 2000-10-04 Azabicykiske 5HT 1 reseptorligander NO20005004L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8123798P	1998-04-09	1998-04-09
PCT/IB1999/000457 WO1999052907A1 (en)	1998-04-09	1999-03-18	Azabicyclic 5ht1 receptor ligands

Publications (2)

Publication Number	Publication Date
NO20005004D0 NO20005004D0 (no)	2000-10-04
NO20005004L true NO20005004L (no)	2000-11-27

Family

ID=22162936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20005004A NO20005004L (no)	1998-04-09	2000-10-04	Azabicykiske 5HT 1 reseptorligander

Country Status (40)

Country	Link
US (2)	US6525048B1 (no)
EP (1)	EP1070065B1 (no)
JP (1)	JP3496759B2 (no)
KR (1)	KR100378931B1 (no)
CN (1)	CN1117092C (no)
AP (1)	AP1175A (no)
AR (1)	AR015751A1 (no)
AT (1)	ATE248838T1 (no)
AU (1)	AU749254B2 (no)
BG (1)	BG104915A (no)
BR (1)	BR9909522A (no)
CA (1)	CA2327782A1 (no)
CO (1)	CO5080727A1 (no)
CZ (1)	CZ20003684A3 (no)
DE (1)	DE69910997T2 (no)
DK (1)	DK1070065T3 (no)
DZ (1)	DZ2756A1 (no)
EA (1)	EA003400B1 (no)
ES (1)	ES2204154T3 (no)
HR (1)	HRP20000653A2 (no)
HU (1)	HUP0102400A3 (no)
ID (1)	ID26086A (no)
IL (1)	IL138629A0 (no)
IS (1)	IS5641A (no)
MA (1)	MA26619A1 (no)
MY (1)	MY133390A (no)
NO (1)	NO20005004L (no)
NZ (1)	NZ507010A (no)
OA (1)	OA11496A (no)
PA (1)	PA8469101A1 (no)
PE (1)	PE20000413A1 (no)
PL (1)	PL343408A1 (no)
PT (1)	PT1070065E (no)
SK (1)	SK14782000A3 (no)
TN (1)	TNSN99056A1 (no)
TR (1)	TR200002932T2 (no)
TW (1)	TW555758B (no)
WO (1)	WO1999052907A1 (no)
YU (1)	YU59400A (no)
ZA (1)	ZA992596B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6231833B1 (en)	1999-08-05	2001-05-15	Pfizer Inc	2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en)	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
UA75580C2 (uk) *	1999-09-03	2006-05-15	Апбі Холдінгс, Ллк	Застосування дапоксетину або його фармацевтично прийнятної солі в лікарському засобі для лікування розладу статевої функції та промисловий виріб для його застосування
GB2362826A (en) *	2000-06-02	2001-12-05	Lilly Co Eli	A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US6855729B2 (en) *	2001-02-20	2005-02-15	Timothy G. Dinan	Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
AU2004220327B2 (en) *	2003-03-12	2010-06-24	Pfizer Products Inc.	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
BRPI0507250A (pt) *	2004-01-29	2007-06-26	Pfizer Prod Inc	combinações para tratar desordens do snc
JP4559749B2 (ja) *	2004-02-16	2010-10-13	あすか製薬株式会社	ピペラジニルピリジン誘導体
AR048112A1 (es)	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es)	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
CA2571555A1 (en) *	2004-06-22	2006-01-05	Pfizer Products Inc.	Diazabicyclic histamine-3 receptor antagonists
EP1792629A4 (en)	2004-08-25	2010-08-25	Takeda Pharmaceutical	MEANS FOR THE PREVENTION / TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE AND PRECAUTIONARY METHOD FOR THIS
MX2007002842A (es) *	2004-09-10	2007-04-30	Pfizer Prod Inc	Metodos de tratamiento de trastornos cognitivos que usan derivados azabiciclicos de piridiloximetilo y benzoisoxazol.
RU2417082C2 (ru) *	2009-07-14	2011-04-27	Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран)	Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
US10154988B2 (en)	2012-11-14	2018-12-18	The Johns Hopkins University	Methods and compositions for treating schizophrenia
US20210393621A1 (en)	2018-10-26	2021-12-23	The Research Foundation For The State University Of New York	Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
WO2020183011A1 (en)	2019-03-14	2020-09-17	Institut Curie	Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5106849A (en) *	1988-05-24	1992-04-21	American Home Products Corporation	Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
WO1990008148A1 (en) *	1989-01-23	1990-07-26	Pfizer Inc.	Bis-aza-bicyclic anxiolytic agents
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
JPH08827B2 (ja) *	1991-09-25	1996-01-10	フアイザー・インコーポレイテツド	精神弛緩剤の２−置換パーヒドロ−１Ｈ−ピリド［１，２−ａピラジン
US5262428A (en) *	1992-03-13	1993-11-16	Wake Forest University	Biologically active tropane derivatives
JP2753146B2 (ja) *	1992-06-16	1998-05-18	ファイザー・インコーポレーテッド	ビス−アザー二環式抗不安薬の製法および中間体
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
WO1996010570A1 (en) *	1994-09-30	1996-04-11	Pfizer Inc.	NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US5614523A (en) *	1995-01-17	1997-03-25	Eli Lilly And Company	Compounds having effects on serotonin-related systems

1999
- 1999-03-17 PA PA19998469101A patent/PA8469101A1/es unknown
- 1999-03-18 WO PCT/IB1999/000457 patent/WO1999052907A1/en not_active Ceased
- 1999-03-18 US US09/403,892 patent/US6525048B1/en not_active Expired - Fee Related
- 1999-03-18 EA EA200000910A patent/EA003400B1/ru not_active IP Right Cessation
- 1999-03-18 KR KR10-2000-7011167A patent/KR100378931B1/ko not_active Expired - Fee Related
- 1999-03-18 NZ NZ507010A patent/NZ507010A/en unknown
- 1999-03-18 PL PL99343408A patent/PL343408A1/xx not_active Application Discontinuation
- 1999-03-18 JP JP2000543464A patent/JP3496759B2/ja not_active Expired - Fee Related
- 1999-03-18 CN CN99807195A patent/CN1117092C/zh not_active Expired - Fee Related
- 1999-03-18 ID IDW20002017A patent/ID26086A/id unknown
- 1999-03-18 PT PT99945686T patent/PT1070065E/pt unknown
- 1999-03-18 AU AU32687/99A patent/AU749254B2/en not_active Ceased
- 1999-03-18 ES ES99945686T patent/ES2204154T3/es not_active Expired - Lifetime
- 1999-03-18 CZ CZ20003684A patent/CZ20003684A3/cs unknown
- 1999-03-18 HU HU0102400A patent/HUP0102400A3/hu unknown
- 1999-03-18 AT AT99945686T patent/ATE248838T1/de not_active IP Right Cessation
- 1999-03-18 EP EP99945686A patent/EP1070065B1/en not_active Expired - Lifetime
- 1999-03-18 HR HR20000653A patent/HRP20000653A2/hr not_active Application Discontinuation
- 1999-03-18 TR TR2000/02932T patent/TR200002932T2/xx unknown
- 1999-03-18 SK SK1478-2000A patent/SK14782000A3/sk unknown
- 1999-03-18 BR BR9909522-0A patent/BR9909522A/pt not_active Application Discontinuation
- 1999-03-18 YU YU59400A patent/YU59400A/sh unknown
- 1999-03-18 DK DK99945686T patent/DK1070065T3/da active
- 1999-03-18 DE DE69910997T patent/DE69910997T2/de not_active Expired - Fee Related
- 1999-03-18 IL IL13862999A patent/IL138629A0/xx unknown
- 1999-03-18 CA CA002327782A patent/CA2327782A1/en not_active Abandoned
- 1999-04-02 TW TW088105301A patent/TW555758B/zh not_active IP Right Cessation
- 1999-04-05 PE PE1999000270A patent/PE20000413A1/es not_active Application Discontinuation
- 1999-04-07 TN TNTNSN99056A patent/TNSN99056A1/fr unknown
- 1999-04-07 DZ DZ990057A patent/DZ2756A1/xx active
- 1999-04-07 MY MYPI99001344A patent/MY133390A/en unknown
- 1999-04-07 MA MA25527A patent/MA26619A1/fr unknown
- 1999-04-07 AR ARP990101572A patent/AR015751A1/es unknown
- 1999-04-08 AP APAP/P/1999/001502A patent/AP1175A/en active
- 1999-04-08 ZA ZA9902596A patent/ZA992596B/xx unknown
- 1999-04-09 CO CO99021093A patent/CO5080727A1/es unknown
2000
- 2000-09-26 IS IS5641A patent/IS5641A/is unknown
- 2000-10-04 NO NO20005004A patent/NO20005004L/no not_active Application Discontinuation
- 2000-10-06 OA OA1200000273A patent/OA11496A/en unknown
- 2000-11-07 BG BG104915A patent/BG104915A/xx unknown
2003
- 2003-02-11 US US10/364,804 patent/US6887905B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1117092C (zh)	2003-08-06
NO20005004D0 (no)	2000-10-04
TR200002932T2 (tr)	2001-01-22
CA2327782A1 (en)	1999-10-21
JP3496759B2 (ja)	2004-02-16
MA26619A1 (fr)	2004-12-20
AP1175A (en)	2003-06-04
EA200000910A1 (ru)	2001-04-23
US6525048B1 (en)	2003-02-25
SK14782000A3 (sk)	2002-06-04
AP9901502A0 (en)	1999-06-30
NZ507010A (en)	2003-05-30
BG104915A (en)	2001-07-31
ID26086A (id)	2000-11-23
JP2002511469A (ja)	2002-04-16
EP1070065B1 (en)	2003-09-03
US20030181458A1 (en)	2003-09-25
IS5641A (is)	2000-09-26
ES2204154T3 (es)	2004-04-16
MY133390A (en)	2007-11-30
WO1999052907A1 (en)	1999-10-21
HUP0102400A3 (en)	2002-10-28
CZ20003684A3 (cs)	2002-03-13
PL343408A1 (en)	2001-08-13
OA11496A (en)	2004-05-14
CO5080727A1 (es)	2001-09-25
BR9909522A (pt)	2000-12-19
HRP20000653A2 (en)	2001-04-30
PE20000413A1 (es)	2000-05-25
CN1305477A (zh)	2001-07-25
AU749254B2 (en)	2002-06-20
ZA992596B (en)	2000-10-08
PA8469101A1 (es)	2000-09-29
DE69910997D1 (de)	2003-10-09
AU3268799A (en)	1999-11-01
EA003400B1 (ru)	2003-04-24
PT1070065E (pt)	2003-12-31
EP1070065A1 (en)	2001-01-24
YU59400A (sh)	2003-10-31
HUP0102400A2 (hu)	2001-11-28
IL138629A0 (en)	2001-10-31
DE69910997T2 (de)	2004-05-19
KR100378931B1 (ko)	2003-04-07
HK1035719A1 (en)	2001-12-07
ATE248838T1 (de)	2003-09-15
DZ2756A1 (fr)	2003-09-15
US6887905B2 (en)	2005-05-03
TNSN99056A1 (fr)	2005-11-10
DK1070065T3 (da)	2003-11-24
AR015751A1 (es)	2001-05-16
KR20010042527A (ko)	2001-05-25
TW555758B (en)	2003-10-01

Publication	Publication Date	Title
DE69719354D1 (de)	2003-04-03	Muscarin-antagonisten
DE69734833D1 (de)	2006-01-12	Vitronektin rezeptor antagonisten
DE69928945D1 (de)	2006-01-19	4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
EP0934305A4 (en)	2001-04-11	INTEGRINANTAGONISTS
EP0986385A4 (en)	2001-05-16	GONADORELIN ANTAGONISTS
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
FI974092L (fi)	1999-04-30	Paikallisverkko
EP0946164A4 (en)	2000-08-23	INTEGRIN ANTAGONISTS
ATE280157T1 (de)	2004-11-15	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20005004D0 (no)	2000-10-04	Azabicykiske 5HT 1 reseptorligander
GB9625843D0 (en)	1997-01-29	Phenyl spiroethercycloalkyl tachykinn receptor antagonists
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
DE59904577D1 (de)	2003-04-17	Metallocenkomplexe
IL140249A0 (en)	2002-02-10	Muscarinic antagonists
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
BR9707733A (pt)	1999-07-27	Antagonistas de receptores muscarinicos oxa-e-tia-diazol
DK0708105T3 (da)	1999-08-23	5-HT4-receptoragonister
DE69926606D1 (de)	2005-09-15	Plazentaprotein 13
DE69431672D1 (de)	2002-12-12	Adrenergischer rezeptor
NO20005551D0 (no)	2000-11-03	2"-deoksyhygromycinderivater
DE59802623D1 (de)	2002-02-21	Pfandschlosseinheit
BR9510060A (pt)	1998-06-02	Receptor
FR2784878B1 (fr)	2000-12-08	Accoudoir
NO996127D0 (no)	1999-12-10	13-dihydro-3'-aziridino-antracykliner
KR960021387U (ko)	1996-07-18	회전시트

Legal Events

Date	Code	Title	Description
2005-10-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application
2010-06-07	FC2A	Withdrawal, rejection or dismissal of laid open patent application